Pulse Biosciences, Inc. PLSE
$25.43
▼ -9.37% 24H
About
Pulse Biosciences, Inc. is a bioelectric medicine company specializing in the development of novel Nanosecond Pulsed Field Ablation (nsPFA) platforms. Its primary focus centers on the patented nPulse technology, which enables precise, non-thermal ablation of soft tissues for applications in dermatology, cardiology, and…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Instruments & Supplies
CountryUnited States
Employees116
TickerPLSE
Statistics
Market Cap$1.73B
Revenue (TTM)$350000
Net Income-$72.8M
Net Margin-20794.6%
EPS—
P/E-25.10
P/S2478.09
P/B27.66
EV/EBITDA-21.84
ROE-80.7%
Dividend Yield—
Price$25.43
Data: Twelve Data · Revenue = mcap / P/S